Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Dan Cole
AddedMar 31, 2024
UpdatedMay 31, 2026
Dan Cole

Dan Cole

Co-Founder, Spray Venture Partners

Crunchbase

Dan Cole's Career

Spray Venture Partners
Spray Venture Partners

Newton, MA, US

Co-Founder
Tryton Medical
Tryton Medical

Durham, NC, US

Board Member· Board
Direct Flow Medical
Direct Flow Medical

Santa Rosa, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Dan Cole's Career

Spray Venture Partners
Spray Venture Partners
Investment FirmInvestment Firm7Newton, MA, US
Co-Founder

Leadership at Spray Venture Partners

Kevin ConnorsKevin ConnorsCo-Founder
Tryton Medical
Tryton Medical
Acquired$104.3M02004Durham, NC, US
Board Member· Board

Leadership at Tryton Medical

Alejandro SanchezAlejandro SanchezBoard Member
Aaron KaplanAaron KaplanCo-Founder
Jay W. SchmelterJay W. SchmelterBoard Member
Carl St. BernardCarl St. BernardCEO
Daniel ColeDaniel ColeCo-Founder
H Richard DavisH Richard DavisCo-Founder
Direct Flow Medical
Direct Flow Medical
Acquired$200.8M02004Santa Rosa, CA, US
Board Member· Board

Leadership at Direct Flow Medical

Mike DeVriesMike DeVriesBoard Member
Paul LaviolettePaul LavioletteBoard Member
Renee RyanRenee RyanBoard Member
Gordon BishopGordon BishopBoard Member

Similar to Direct Flow Medical

Flow MedicalFlow MedicalChicago, IL, USMedical Devicesest. 2020Flow MedicalChicago, IL, US · est. 2020

Flow Medical: Providing multi-function catheters for diagnosis and treatment of venous diseases.

Seed · $1.2M9
ClearFlowClearFlowAnaheim, CA, USMedical Devicesest. 1992ClearFlowAnaheim, CA, US · est. 1992

ClearFlow Inc. develops innovative devices for resolving obstructed catheters across various medical segments.

Series A · $39.7M31

Dan Cole's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Dan Cole

David StuckenbergDavid StuckenbergCo-Founder · Genesis SystemsAdam ScottAdam ScottCo-Founder · Compact MedicalDavid DworaczykDavid DworaczykBoard Member · Bryn PharmaAmin RahmeAmin RahmeCEO · MedTech ExchangeDaniel OlmesDaniel OlmesCo-Founder · Hellen SystemsAndrew SklawerAndrew SklawerCo-Founder · Fresh Tracks Therapeutics